Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

S'inscrire

BCRX BioCryst Pharmaceuticals Inc

7,71

-0,01 (-0,13%)

28 Déc 2024 - Fermé

Retardé de 15 minutes

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

The sale reported on this Form 144 was made pursuant to a Rule 10b5-1 trading plan previously entered into by the reporting person for the sole purpose of generating sufficient proceeds to cover the tax liability incurred in connection with the vesting of previously granted restricted stock units.

Date of Notice

12/13/2024

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

06/18/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

Nancy J Hutson

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

BioCryst Pharmaceuticals (NASDAQ:BCRX)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024

Plus de graphiques de la Bourse BioCryst Pharmaceuticals

BioCryst Pharmaceuticals (NASDAQ:BCRX)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024

Plus de graphiques de la Bourse BioCryst Pharmaceuticals

Actualités BioCryst Pharmaceuticals Inc

Form 4 - Statement of changes in beneficial ownership of securities
Lundi 23 Décembre 2024 ( il y a 6 jours) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Lundi 23 Décembre 2024 ( il y a 6 jours) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Lundi 23 Décembre 2024 ( il y a 6 jours) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Lundi 23 Décembre 2024 ( il y a 6 jours) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Lundi 23 Décembre 2024 ( il y a 6 jours) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mardi 17 Décembre 2024 ( il y a 2 semaines) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mardi 17 Décembre 2024 ( il y a 2 semaines) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mardi 17 Décembre 2024 ( il y a 2 semaines) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mardi 17 Décembre 2024 ( il y a 2 semaines) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mardi 17 Décembre 2024 ( il y a 2 semaines) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Lundi 16 Décembre 2024 ( il y a 2 semaines) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Vendredi 13 Décembre 2024 ( il y a 2 semaines) • Edgar (US Regulatory)

Plus d'articles sur BioCryst Pharmaceuticals Inc

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales